References
- Delmas P. La gla-proteine osseuse. Facteur physiologique et nouveau marqueur biologique en pathologic osseuse. Nouv Press Med 1982; 11: 2555–2557
- Hauschka P V, Lian J B, Gallop P M. Direct identification of the calcium-binding amino acid, γ-carboxyglutamate, in mineralized tissue. Proc Natl Acad Sci (USA) 1975; 72: 3925–3929
- Price P A, Otsuka A S, Poser J W, et al. Characterization of a γ-carboxyglutamic acid containing protein from bone. Proc Natl Acad Sci (USA) 1976; 73: 1447–1451
- Nishimoto S K, Price P A. Secretion of the vitamin K-dependent protein of bone by rat osteosarcoma cells. J Biol Chem 1980; 255: 6579–6583
- Gundberg C M, Andersen M, Dickson I, Galloy P M. Glycated osteocalcin in human and bovine bone. J Biol Chem 1986; 261: 14557–14561
- Delmas P D, Stenner D, Wahner H W, et al. Serum bone Gla protein increases with aging in normal woman: implications for age-related bone loss. J Clin Invest 1983; 71: 1316–1321
- Price P A, Williamson M K, Latheinger J W. Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone. J Biol Chem 1981; 256: 12760–12766
- Lian J B, Ranfosse A H, Reit B, Glimcher M J. Concentrations of osteocalcin and phosphoprotein as a function of mineral content and age in cortical bone. Calcif Tissue Int 1982; 34: 584
- World Health Organization. Handbook for Reporting Results of Cancer Treatment. WHO, Geneva 1979, WHO Offset Publ 48
- Karnofsky D A, Burchenal J M. The clinical evaluation of chemotherapeutic agents. Evaluation of Chemotherapeutic Agents, McLead. Columbia University Press, New York 1949; 191–203
- Delmas P D. Bone-Gla-Protein (Osteocalcin): A specific marker for the study of metabolic bone disease. Calciotropic Hormones and Calcium Metabolism, M Cecchettin, G Segre. Elsevier Science Publishers BW, Amsterdam 1986; 19–27
- Gundberg C M, Cole D EC, Lian J B, et al. Serum osteocalcin in the treatment of inherited rickets with 1,25-dihydroxyvitamin D. J Clin Endocrinol Metab 1983; 56: 1063–1067
- Gundberg C M, Lian J B, Gallop P M, Steinberg J J. Urinary γ-carboxyglutamic acid and serum osteocalcin as bone markers: studies in osteoporosis and Paget's disease. J Clin Endocrinol Metab 1983; 57: 1221–1225
- Delmas P D, Stenner D, Wahner H W, et al. Increase in serum bone γ-carboxyglutamic acid protein with aging in women: implications for the mechanism of age-related bone loss. J Clin Invest 1983; 71: 1316–1321
- Delmas P D, Wahner H W, Mann K G, Riggs B L. Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Gla-protein. J Lab Clin Med 1983; 102: 470–476
- Slovik D M, Gunderberg C M, Neer R M, Lian J B. Clinical evaluation of bone turnover by serum osteocalcin measurements in a hospital setting. J Clin Endocrinol Metab 1984; 59: 228–230
- Delmas P D, Demiaux B, Malavel L, et al. L'osteocalcine (ou Gla-proteine osseuse), nouveau marqueur biologique pour l'ètude de la pathologie osseuse. La Presse Medicale 1986; 14: 643–646
- Gundberg C M, Weinstein R S. Multiple immunoreactive forms of osteocalcin in uremic serum. J Clin Invest 1986; 77: 1762–1767
- Jain K K, Casper E S, Geller N L, et al. A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer. J Clin Oncol 1985; 3: 818–826
- Henderson C., Canellos G. Cancer of the breast—the past decade II. N Engl J Med 1980; 302: 78–90
- Neri B, Pacini P, Bartalucci S, Cappellini M. Epirubicin high dose therapy in advanced breast cancer: preliminary clinical date. 6 Deutsch-Italienisches Onkologisches Symposium, Berlin, October, 13–151988
- Brown J P, Delmas P D, Malaval L, et al. Serum bone Gla-protein: A specific marker for bone formation in postmenopausal osteoporosis. Lancet 1984; 13: 1091–1093